Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 210Triple Negative Breast Neoplasms 32Stomach Neoplasms 30Inflammatory Breast Neoplasms 21Esophageal Neoplasms 15Carcinoma, Hepatocellular 15Lymphoma, Large B-Cell, Diffuse 9Sarcoma 8Neoplasms 8Non-Muscle Invasive Bladder Neoplasms 6Urinary Bladder Neoplasms 5Breast Neoplasms, Male 5Adenocarcinoma Of Esophagus 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Lymphoma 4Liver Neoplasms 4Testicular Neoplasms 3Primary Breast Cancer 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pathologic Complete Response 3Hemangiosarcoma 3Carcinoma, Ductal, Breast 3Unspecified Adult Solid Tumor, Protocol Specific 2Recurrence 2Prostatic Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplastic Cells, Circulating 2Neoplasms, Germ Cell and Embryonal 2

Interventions

Etoposide 17Filgrastim 16Carboplatin 16Ifosfamide 15Peripheral Blood Stem Cell Transplantation 14Cisplatin 14Paclitaxel 12Cyclophosphamide 8Bleomycin 7Radiotherapy 6pegfilgrastim 4Thiotepa 4etoposide phosphate 3sargramostim 2aldesleukin 2Vinblastine 2Temozolomide 2Methylprednisolone 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Granisetron 2Gemcitabine 2Dexamethasone 2Busulfan 2Alemtuzumab 2tislelizumab 1sabarubicin 1milademetan 1lerisetron 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Testicular Germ Cell Tumor × Epirubicin × Clear all
NCT00003852 2016-06-23

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

UNICANCER

Phase 2 Terminated
45 enrolled
GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡